With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genetically Engineered T Cells as Therapy for Pediatric Glioma||Baylor College of Medicine / Giedre Krenciute, PhD||Young Investigator Grants||2016||Texas|
|The Role of ARID1A in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Hui Shi, PhD||Young Investigator Grants||2016||Massachusetts|
|Bad Influence: EWS/FLI Alters LSD1 and NuRD Interactions to Enforce Oncogenic Function in Ewing’s||Research Institute at Nationwide Children's Hospital / Emily Theisen, PhD||Young Investigator Grants||2016||Ohio|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|
|A CRISPRi Genetic Screen in Ewing sarcoma Identifies a Novel Dependence on Homologous Recombination DNA Repair||University of California San Francisco / Asmin Tulpule, MD/PhD||Young Investigator Grants||2016||California|
|Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression||University of Colorado Denver / Melanie Vincent, PhD||Young Investigator Grants||2016||Colorado|
|Investigating Racial Disparities in Pediatric Acute Leukemia||University of California San Francisco / Lena Winestone, MD||Young Investigator Grants||2016||California|
|Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma||National Cancer Institute / Marielle Yohe, MD/PhD||Young Investigator Grants||2016||Maryland|
|Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma||University of Pennsylvania / Nicole Anderson, PhD||Young Investigator Grants||2016||Pennsylvania|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|